Compare · MEDP vs ONMD
MEDP vs ONMD
Side-by-side comparison of Medpace Holdings Inc. (MEDP) and OneMedNet Corp (ONMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MEDP and ONMD operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- MEDP is the larger of the two at $13.08B, about 348.0x ONMD ($37.6M).
- MEDP has been more active in the news (10 items in the past 4 weeks vs 2 for ONMD).
- MEDP has more recent analyst coverage (25 ratings vs 0 for ONMD).
- Company
- Medpace Holdings Inc.
- OneMedNet Corp
- Price
- $457.81+0.76%
- $0.71+4.08%
- Market cap
- $13.08B
- $37.6M
- 1M return
- +6.68%
- -
- 1Y return
- +53.60%
- -
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2021
- News (4w)
- 10
- 2
- Recent ratings
- 25
- 0
Medpace Holdings Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Latest MEDP
- New insider Hansman Brad W. claimed ownership of 697 shares (SEC Form 3)
- SEC Form 8-K filed by Medpace Holdings Inc.
- General Counsel & Corp. Secy. Ewald Stephen P exercised 16,349 shares at a strike of $138.87 and sold $7,357,050 worth of shares (16,349 units at $450.00) (SEC Form 4)
- SEC Form 8-K filed by Medpace Holdings Inc.
- SEC Form 4 filed by Director Zander Dani S.
- SEC Form 4 filed by Director Mccarthy Cornelius P. Iii
- SEC Form 4 filed by Director Kraft Robert O.
- SEC Form 4 filed by Director Gwadry-Sridhar Femida H.
- SEC Form 4 filed by Director Davenport Fred B Jr
- SEC Form 4 filed by Director Carley Brian T
Latest ONMD
- OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
- Director Kosasa Thomas bought $250,000 worth of shares (268,817 units at $0.93), increasing direct ownership by 2% to 16,930,144 units (SEC Form 4)
- SEC Form 424B3 filed by OneMedNet Corp
- SEC Form 10-Q filed by OneMedNet Corp
- Amendment: SEC Form 10-K/A filed by OneMedNet Corp
- Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)
- Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)
- OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
- OneMedNet Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data